US journalist Katherine Eban posted on May 15 a detailed account of practices at Ranbaxy. Although I cannot comment on everything in her story, it is encouraging to see the US media take an active interest in public health and the extraordinary circumstances at Ranbaxy. With so much of this conduct tracing to India, certainly it is a matter of time before India follows suit.

My concerns for the well-being of people taking Ranbaxy drugs motivated me to act. Now that these practices have come to light, I hope that others understand why this was the right thing to do.